Decentralized Trial Technology Resources

  1. The Role Of mHealth Technologies In Clinical Care And Clinical Research 7/12/2022

    Discover how mobile health (or mHealth) solutions provide increased access to care, making it easier for patients to receive care and for healthcare professionals to deliver that care.

  2. The Language Of eCOAs 6/3/2022

    In this article, learn more about COAs, and their electronic counterparts, eCOAs.

  3. The Definitive Guide To Decentralized Clinical Trials 6/8/2023

    See how the clinical trial landscape has changed, and why many sponsors are choosing to make digital and decentralized trials a key part of their future.

  4. Top 10 Challenges And Solutions For Decentralized Clinical Trials 5/13/2025

    Decentralized clinical trials are reshaping research, but what are the biggest roadblocks to their full potential? We delve into the top 10 challenges and the cutting-edge solutions emerging.

  5. FDA Releases Updated Draft Guidance On Decentralized Clinical Trials 6/12/2023

    Take a closer look at the FDA's draft guidance on designing and implementing DCTs, notably remote trial visits, the use of digital health technologies, institutional review board oversight, and more.

  6. The Transformative Role Of Digital Health Technologies 3/12/2025

    Digital health technologies are transforming clinical trials through decentralization, improved data, and patient-centric approaches, driving efficiency and accessibility.

  7. Beyond Integration: Flexible Orchestration Of IRT And eCOA Solutions 4/25/2023

    Consider how integrated response technologies and electronic clinical outcomes assessments can improve configurability, study start-up, and flexible mid-study changes.

  8. Televisits To Support Patient Engagement In Decentralized Clinical Trials 10/26/2023

    Discover how embedding a televisit feature directly into an eCOA app brings multiple benefits to patients and sites.

  9. How DCTs Became The New Standard 10/30/2023

    See how the core features of DCTs have become the new default clinical trial practices for a variety of therapeutic areas, almost four years after the 2020 pandemic brought about their rise.

  10. 4 Ways Home Visits Support Successful Rare Disease Clinical Trials 4/25/2023

    Researchers, patients, pharma, and regulators face several obstacles when designing and conducting rare disease trials. Here, we delve into the importance of home visits in rare disease clinical trials.